Delivery Order SPE2DB22D1106-SPE2DB25FDJE3

Award Date 10/28/24
Potential Completion Date 10/29/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The award, valued at $6,179.40, is a Delivery Order contract for the supply of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,715.24 firm-fixed-price delivery order is for the supply of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract has an ultimate completion date of December 13, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical,...
This federal contract award, valued at $4,747.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for the supply of EMVERM 100 MG TABLET CHEW UDS, a medical product, with a period of performance through May 1, 2025. The award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp is a Firm Fixed Price Delivery Order worth $2,183.96 to provide 4557842219 - EMVERM 100 MG TABLET CHEW UDS to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 20, 2022 and was awarded on July 19, 2022. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,450.35 firm fixed-price delivery order is for the supply of the medication EMVERM 100 MG TABLET CHEW UDS, with a completion date of June 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,707.62 firm fixed-price delivery order is for the provision of 4567421566 ! EMVERM 100 MG TABLET CHEW UDS medical supplies. The contract has a period of performance through March 3, 2025 and was awarded on February 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,774.92, is a delivery order for the supply of EMVERM 100 MG TABLET CHEW UDS medical products. It is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, with ID SPE2DB22D2007|SPE2DB25FJ0ZY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,213.77 firm fixed-price delivery order is for the supply of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract has an ultimate completion date of April 28, 2025 and was awarded on April 25, 2025. It is not a set-aside contract, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The award is a Delivery Order contract valued at $9,077.19 with a Firm Fixed Price pricing type. The contract is for the supply of EMVERM 100 MG TABLET CHEW UDS pharmaceutical products. This contract is not designated as a set-aside. Amerisourcebergen, as one of the largest pharmaceutical distributors in the U.S., leverages its extensive...
This is a $8,389.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EMVERM 100 MG TABLET CHEW UDS medical products, with a period of performance through June 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDJE3
    Delivery Order

This federal contract award is for the delivery of the pharmaceutical product EMVERM 100 MG TABLET CHEW UDS, issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $13,659.92, is a firm fixed-price delivery order with a completion date of October 29, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/2/25, 12:08 AM